TargetMol中国(陶术生物) 公司信息
公司名称:
TargetMol中国(陶术生物)
电话:
-
电子邮件:
marketing@targetmol.com
国籍:
中国
网址:
https://www.targetmol.cn/
产品总数:
28118
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
公司提供产品列表
Leu5]-Enkephalin TFA(58822-25-6(free bas));Leu-enkephalin|||Leucine enkephalin|||Leucyl-enkephalin
化合物[Leu5]-Enkephalin TFA;Leu-enkephalin|||Leucine enkephalin|||Leucyl-enkephalin
73563-78-7
Luxdegalutamide;ARV-766
化合物Luxdegalutamide;ARV-766
2750830-09-0
Brentuximab;
布妥昔单抗;
2088770-90-3
Conatumumab;TRAIL-R2 mAb|||AMG 655
西他土珠;TRAIL-R2 mAb|||AMG 655
896731-82-1
Glucose oxidase;
葡萄糖氧化酶;
9001-37-0
CDP-Star;
化合物 CDP-Star;
160081-62-9
Farletuzumab;MORAb-003
法妥组单抗;MORAb-003
896723-44-7
Aprutumab;FGFR-moAb|||FGFR2-TTC|||BAY 1179470
阿普卢妥单抗;FGFR-moAb|||FGFR2-TTC|||BAY 1179470
1634620-63-5
Inotuzumab;
英妥珠单抗;
1660159-36-3
Survodutide;BI 456906
化合物Survodutide;BI 456906
2805997-46-8
TGFβ1-IN-3;
TGFβ1抑制剂3;
2883813-58-7
Zilovertamab;Cirmtuzumab|||UC-961
泽罗妥单抗;Cirmtuzumab|||UC-961
1643432-38-5
Fletikumab;Anti-IL-20|||NN-8226|||NNC 0109-0012
夫来库单抗;Anti-IL-20|||NN-8226|||NNC 0109-0012
1357158-22-5
Bermekimab;MABp1
贝迈奇单抗;MABp1
1401965-15-8
Inebilizumab;MEDI 551|||MT-0551|||16C4-aFuc|||VIB-0551
伊奈利珠单抗;MEDI 551|||MT-0551|||16C4-aFuc|||VIB-0551
1299440-37-1
Mosunetuzumab;
莫妥珠单抗;BTCT-4465A
1905409-39-3
Rolinsatamab;
洛林妥单抗;
2095467-30-2
Mupadolimab;CPI-006
莫帕利单抗;CPI-006
2451856-97-4
Angiotensin 1/2 (1-9) TFA;Angiotensin 1/2 (1-9) TFA (34273-12-6 free base)
Angiotensin 1/2 (1-9) TFA 三氟乙酸盐;Angiotensin 1/2 (1-9) TFA (34273-12-6 free base)
Norgestimate;
诺孕酯;炔诺肟酯|||诺孕酯
35189-28-7
MitoSOX Red;
化合物MitoSOX Red;
1003197-00-9
DPro10] Dynorphin A (1-11)acetate,porcine;[DPro10] Dynorphin A (1-11)acetate,porcine(94596-26-6 Free base)
DPro10] Dynorphin A (1-11)acetate(猪);[DPro10] Dynorphin A (1-11)acetate,porcine(94596-26-6 Free base)
Anti-inflammatory agent 42;
抗炎剂42;
877468-30-9
(±)-Liquiritigenin;(±)-4',7-Dihydroxyflavanone
化合物 (±)-Liquiritigenin;(±)-4',7-Dihydroxyflavanone
69097-97-8
Adropin (34-76) (human, mouse, rat);
Adropin (34-76)(人,小鼠,大鼠);
1802086-30-1
Sifalimumab;MDX-1103|||MEDI-545
西法木单抗;MDX-1103|||MEDI-545
1006877-41-3
Enokizumab;MEDI-528
依诺凯组单抗;MEDI-528
909875-08-7
Onartuzumab;RG-3638|||PRO-14396|||MetMAb
奥那妥组单抗;RG-3638|||PRO-14396|||MetMAb
1133766-06-9
Emibetuzumab;LY2875358
依玛妥珠单抗;LY2875358
1365287-97-3
Rovalpituzumab;
洛伐妥珠单抗;
1613313-01-1
Tislelizumab;
化合物 Tislelizumab;替雷利珠
1858168-59-8
Ac-Pro-Gly-Pro-OH;
化合物 Ac-Pro-Gly-Pro-OH;
292171-04-1
GW297361;
化合物GW297361;
388627-21-2
Ac-FEID-CMK TFA;
Ac-FEID-CMK 三氟乙酸盐;
Golimumab;MK-8259|||SCH 900259|||CNTO-148
戈利木单抗;MK-8259|||SCH 900259|||CNTO-148
476181-74-5
Deltorphin 2;Deltorphin 2(TFA)|||[D-Ala2]-Deltorphin II
化合物Deltorphin 2(TFA);Deltorphin 2(TFA)|||[D-Ala2]-Deltorphin II
122752-16-3
Eldelumab;BMS-936557|||MDX-1100
埃迪鲁单抗;BMS-936557|||MDX-1100
946414-98-8
Cibisatamab;
赛必妥单抗;
1855925-27-7
Pepinh-TRIF TFA;
多肽Pepinh-TRIF 三氟乙酸盐;
Senktide acetate;Senktide acetate(106128-89-6 free base)
Senktide 醋酸盐;Senktide acetate(106128-89-6 free base)
Isoxanthohumol;
异黄腐醇;
521-48-2
Galcanezumab;LY 2951742
加那珠单抗;LY 2951742
1578199-75-3
Sarilumab;REGN-88|||SAR-153191
萨瑞鲁单抗;REGN-88|||SAR-153191
1189541-98-7
Nepasaikosaponin K;
化合物 Nepasaikosaponin K;
405229-61-0
Amatuximab;MORab-009
阿麦妥单抗;MORab-009
931402-35-6
Rilotumumab;AMG 102
利妥木单抗;AMG 102
872514-65-3
Mavrilimumab;CAM 3001
玛弗利木单抗;CAM 3001
1085337-57-0
Demcizumab;
登赛珠单抗;OMP 21M18
1243262-17-0
Teplizumab;PRV-031|||MGA-031
替利组单抗;PRV-031|||MGA-031
876387-05-2
PKA Inhibitor Fragment (6-22) amide TFA;PKI-(6-22)-amide TFA|||PKA Inhibitor Fragment (6-22) amide TFA(121932-06-7 Free base)
PKA Inhibitor Fragment (6-22) amide三氟乙酸盐;PKI-(6-22)-amide TFA|||PKA Inhibitor Fragment (6-22) amide TFA(121932-06-7 Free base)
Taurodeoxycholic acid;Taurodeoxychloic acid
牛磺异熊去氧胆酸;Taurodeoxychloic acid
516-50-7
Ser-Ala-alloresact acetate;Ser-Ala-alloresact acetate(140653-27-6 Free base)
Ser-Ala-alloresact醋酸盐;Ser-Ala-alloresact acetate(140653-27-6 Free base)
(E/Z)-Squalene;(E/Z)-Super Squalene|||(E/Z)-AddaVax
(E/Z)角鲨烯;(E/Z)-Super Squalene|||(E/Z)-AddaVax
7683-64-9
Thrombospondin-1 (1016-1023) (human, bovine, mouse);
Thrombospondin-1 (1016-1023) (人, 牛, 鼠);
149234-04-8
Mogamulizumab;KW-0761
莫格利珠单抗;KW-0761
1159266-37-1
Tuftsin;Tuftsin(3TFA)
化合物Tuftsin;Tuftsin(3TFA)
9063-57-4
Fezakinumab;ILV 094
非扎奴单抗;ILV 094
1007106-86-6
Simtuzumab;GS 6624|||AB 0024
辛妥珠单抗;GS 6624|||AB 0024
1318075-13-6
Tildrakizumab;
替瑞奇珠单抗;MK 3222|||SCH 900222
1326244-10-3
Monalizumab;
莫那利珠单抗;
1228763-95-8
Emapalumab;NI-0501
依马利尤单抗;NI-0501
1709815-23-5
Onvatilimab;JNJ-61610588
奥瓦利单抗;JNJ-61610588
1969313-51-6
Glofitamab;RO7082859|||RG 6026|||CD20-TCB
格菲妥单抗;RO7082859|||RG 6026|||CD20-TCB
2229047-91-8
EGFR-IN-76;
化合物EGFR-IN-76;
2607829-38-7
6-Thioinosine;6-Mercaptopurine riboside|||6TI
6-疏基嘌呤核苷;6-Mercaptopurine riboside|||6-疏基嘌呤核苷|||6TI
574-25-4
Sar1, Ile8]-Angiotensin II acetate;
化合物[Sar1, Ile8]-Angiotensin II acetate;
67724-27-0
Tralokinumab;CAT-354|||LP 0162
曲罗芦单抗;CAT-354|||LP 0162
1044515-88-9
Ibalizumab;TNX-355|||TMB-355
艾巴利珠单抗;TNX-355|||TMB-355
680188-33-4
Parsatuzumab;RG 7414|||Anti-EGFL7|||MEGF0444A|||MEGF-0444A|||RO-5490248|||M0444A
帕萨妥珠单抗;RG 7414|||Anti-EGFL7|||MEGF0444A|||MEGF-0444A|||RO-5490248|||M0444A
1312797-14-0
Bococizumab;RN316|||PF-04950615
伯考赛珠单抗;RN316|||PF-04950615
1407495-02-6
Nemolizumab;CIM331
奈莫利珠单抗;CIM331
1476039-58-3
Utomilumab;PF 05082566|||PF-2566
乌托鲁单抗;PF 05082566|||PF-2566
1417318-27-4
Bemarituzumab;FPA144
贝玛妥珠单抗;FPA144
1952272-74-0
Sutimlimab;
苏替莫单抗;
2049079-64-1
Cemiplimab;REGN-2810|||SAR-439684
西米普利单抗;REGN-2810|||SAR-439684
1801342-60-8
Sabatolimab;MBG453|||NVP-MBG453
Sabatolimab单抗;MBG453|||NVP-MBG453
2252262-24-9
Teprotumumab;R 1507|||HZN 001
替妥木单抗;R 1507|||HZN 001
1036734-93-6
Zagotenemab;LY33003560
泽格特亲单抗;LY33003560
2019133-28-7
MOG peptide (35-55) , mouse, rat acetate;Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate|||MOG peptide (35-55) , mouse, rat acetate (149635-73-4 Free base)
化合物T7657L;Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate|||MOG peptide (35-55) , mouse, rat acetate (149635-73-4 Free base)
Endo-1,3-β-glucanase;
硫葡糖苷酶白芥子;Lyticase
9025-37-0
Varlilumab;CDX-1127
伐立鲁单抗;CDX-1127
1393344-72-3
Olaratumab;LY3012207|||IMC-3G3
奥拉单抗;LY3012207|||IMC-3G3
1024603-93-7
Indusatumab;
英度妥单抗;
1497400-26-6
Mirvetuximab;M9346A
米妥昔单抗;M9346A
1453084-36-0
GRGDSPK acetate;GRGDSPK acetate(111119-28-9 Free base)
GRGDSPK醋酸盐;GRGDSPK acetate(111119-28-9 Free base)
144027-77-0
Ponsegromab;
Ponsegromab单抗;PF 06946860
2368950-15-4
Retatrutide sodium salt;Retatrutide sodium salt(2381089-83-2 free base)|||LY3437943 sodium salt
Retatrutide钠盐;Retatrutide sodium salt(2381089-83-2 free base)|||LY3437943 sodium salt
2381089-83-2
TGFβ1-IN-2;
TGFβ1抑制剂2;
2700263-58-5
6-Aminonicotinamide;
6-氨基烟酰胺;
329-89-5
Itolizumab;EQ-001
伊利组单抗;EQ-001
1116433-11-4
Myosmine;
麦斯明;麦司明|||麦斯明
532-12-7
SB-435495;
化合物 SB-435495;
304694-39-1
Sar1, Ile8]-Angiotensin II 3TFA;[Sar1, Ile8]-Angiotensin II 3TFA(37827-06-8(free base))
化合物[Sar1, Ile8]-Angiotensin II 3TFA;[Sar1, Ile8]-Angiotensin II 3TFA(37827-06-8(free base))
37827-06-8
Brodalumab;LP 0160|||KHK-4827|||AMG-827
布罗利尤单抗;LP 0160|||KHK-4827|||AMG-827
1174395-19-7
Risankizumab;Risankizumab rzaa|||SKYRIZI|||ABBV 066|||BI-655066
利散吉珠单抗;Risankizumab rzaa|||SKYRIZI|||ABBV 066|||BI-655066
1612838-76-2
Fresolimumab;GC1008
非苏木单抗;GC1008
948564-73-6
Girentuximab;cG250|||WX-G250|||G250
吉妥昔单抗;cG250|||WX-G250|||G250
916138-87-9
Emactuzumab;RO 5509554|||RG 7155
依瑞奈尤单抗;RO 5509554|||RG 7155
1448221-67-7
Serplulimab;HLX 10
斯鲁利单抗;HLX 10
2231029-82-4
HIF-PHD-IN-3;
HIF-PHD抑制剂3;
794582-71-1
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
Copyright 2007© ChemicalBook. All rights reserved.